MedTrace Logo

Effect of Some Drugs on Liver Fibrosis

NCT03770936 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2018-12-10

No results posted yet for this study

Summary

Effect of Some Drugs on Liver Fibrosis

Conditions

  • Liver Fibroses

Interventions

DRUG

Candesartan

Candesartan 8 mg/day

DRUG

Ramipril

ramipril 1.25 mg/day

Sponsors & Collaborators

  • Sherief Abd-Elsalam

    lead OTHER

Principal Investigators

  • Gamal El-azab, Prof · Clinical pharmacy Department- Tanta University

  • Tarek Mostafa, Prof · Cardiology Department- Tanta University

  • Gamal Badra, Prof · National Hepatology Institute - Egypt

  • Abeer El-Motwally, Msc · Clinical pharmacy Department-Tanta University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2026-10-31
Completion
2027-11-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03770936 on ClinicalTrials.gov